Highlights
composition with strength
Minoxidil (5%w/w)
description
Promotes hair growth effectively, prevents further hair loss, suitable for male pattern baldness, easy topical application
key benefits
Treatment of Hair loss
side effects
Scalp irritation, Itching, Minoxidil-Foam, Dry skin, Temporary hair shedding
how to use
For external use only Apply the gel to the affected area after cleaning and drying it Use it as directed by your doctor and check the label for instructions
alcohol interaction
Consult Your Doctor
pregnancy interaction
Unsafe
lactation interaction
Consult Your Doctor
driving interaction
Consult Your Doctor
kidney interaction
Safe
liver interaction
Safe
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 508, Sakti Statesman, 5th floor, Green Glen Layout, No.37/301/34/1, SY.NO.34, Ibblur Village, Begur Hobli, Bangalore, Karnataka-560103
Pharmacy License No.
KA-B62-271538, KA-B62-271539
Manufacturer or Marketer Name
Dabur India Limited
Manufacturer or Marketer Address
8/3, Asaf Ali Road, New Delhi-110002
Country of Origin
India
Shelf Life
24 months
Expires on or after
January 2027
